BiovaxID MCL Study: Overall Survival

MCL Overall Survival (1996-2004)

BiovaxID Phase 2 MCL Study

Hermann  A, et al. J Clin Oncol. 2009 Feb;27:511

Figure 1

Exhibit 99.2

BiovaxID MCL Study: OS: Id-Specific GM-CSF (<> median)

Figure 2

Time-to-Next-Treatment: Id-Specific GM-CSF (<> median)

Figure 3